AABB promotes coverage and reimbursement policies that support patients’ access to blood products, and transfusion services and cellular therapies. The Association educates policymakers, payers, blood centers and providers on the complexities of coding, billing and reimbursement policies, and advocates for improved coverage and reimbursement policies.
CMS Finalizes 2026 Medicare PFS Rule, Updates Biotherapies Payment Policies
November 05, 2025
CMS to Join AABB eCast on Cellular Therapies Coding and Reimbursement
September 10, 2025
AABB, ASFA Urge CMS to Reconsider Reimbursement Policy for CAR T-Cell Therapy
September 09, 2025